Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...
Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q3 2025 investor letter. A copy of ...
StockStory.org on MSN
3 reasons PFS is risky and 1 stock to buy instead
Over the past six months, Provident Financial Services has been a great trade, beating the S&P 500 by 6.6%. Its stock price ...
The Personal Financial Specialist (PFS) certification helps Certified Public Accountants (CPAs) demonstrate an expertise in all aspects of wealth management. A PFS is someone with a CPA who also ...
Topline data were announced from a phase 3 trial evaluating varegacestat in patients with progressing desmoid tumors.
The combination of trabectedin (Yondelis; Pharma Mar, Johnson & Johnson) and olaparib (Lynparza; AstraZeneca, Merck) may be a meaningful treatment for certain patients with advanced soft tissue ...
Although frontline maintenance treatment with fuzuloparib monotherapy produced a progression-free survival (PFS) benefit in patients with newly diagnosed advanced ovarian cancer, the addition of ...
Varegacestat, an investigational gamma secretase inhibitor (GSI), delivered clinically meaningful improvements in efficacy outcomes vs placebo in patients with progressing desmoid tumors, according to ...
The Personal Finance Society (PFS) has announced that over 400 individuals have so far expressed interest in the PFS Pathway ...
More than 400 individuals have expressed interest in the PFS Pathway to the Profession initiative. Launched in July, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback